Alloy

What Alloy does

Alloy is a U.S.-based direct-to-consumer telehealth company founded in 2021 by Monica Molenaar and Anne Fulenwider, both serving as co-CEOs, that specializes in healthcare for women in perimenopause and menopause (approximately ages 40-60). The platform connects patients with NCMP-certified menopause-specialist physicians (delivered via the MDI Health Technologies network) through an asynchronous intake process, with initial consultations completed within 12 hours and ongoing 24/7 messaging access.

The product platform spans six verticals: hormone replacement therapy (estradiol pill/patch/spray/gel, progesterone, paroxetine, low-dose birth control), proprietary prescription skincare (the M4 estriol-based line including Face Cream Rx, Body Treatment Rx, Eye Cream Rx, and Face Serum Rx, plus tretinoin), GLP-1-based weight care (Zepbound, Wegovy pen and oral pill, Foundayo Pill, and compounded semaglutide/tirzepatide/liraglutide with micro-dosing options), sexual health (Estradiol Vaginal Cream and the proprietary O-mazing topical sildenafil cream), hair care (oral minoxidil, spironolactone, bimatoprost lash/brow serum), and gut health (Alloy Synbiotic). For branded GLP-1 fulfillment, Alloy integrates with Eli Lilly's LillyDirect and Novo Nordisk's NovoCare pharmacies.

The business model is primarily subscription-based: a one-time $49.95 consultation fee plus recurring monthly or quarterly product subscriptions billed via Stripe, with HSA/FSA acceptance and cash-pay pricing. Products are compounded and dispensed through partner pharmacies or branded pharmacies and shipped directly to patients' doors. The company is venture-backed with $3.3M in seed (October 2021) and $16M Series A (November 2024), and in July 2025 established its first international presence through a Japan-based joint collaboration with the Kansai Startup Academia Coalition. Reported clinical outcomes include 95% of HRT patients achieving symptom relief within two weeks and 20% average body weight loss over twelve months in the weight care program.

Name

Alloy

Legal name

Alloy Health, Inc.

Website

https://myalloy.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

Alloy is a U.S. direct-to-consumer telehealth platform founded in 2021 that connects women in perimenopause and menopause with NCMP-certified physicians for prescription hormone therapy, weight care, skincare, sexual health, hair care, and gut health treatments delivered to their door.

Ownership category

akta.pro rank

Product category

Women's Menopause Telehealth

NAICS

Health and Personal Care Retailers (456), Cosmetics, Beauty Supplies, and Perfume Retailers (456120)

SIC

Perfumes, Cosmetics & Other Toilet Preparations (2844), Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Women’s Health (OTC Gynecologic) (HLAIADAJ)

akta.pro secondary industries

Treatment Skincare (Serums, Actives, Acne & Anti-aging) (CRABAAAB), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)

Keywords

• Menopause telehealth
• Hormone replacement therapy
• Perimenopause treatment
• GLP-1 weight management
• Prescription skincare

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Marketing or Sales, Technology or R&D, Operations, Others

Revenue model

1. Telehealth Consultation and Prescription Services: One-time consultation fee ($49.95) plus ongoing subscription for doctor access and treatment management. Prescription medications are billed separately (quarterly for most products).
2. Product Sales - Hormone Therapy: Sales of FDA-approved hormone replacement therapy products including estradiol pills, patches, sprays, and gels. Billed quarterly (3-month supplies).
3. Product Sales - Skincare: Sales of M4 estriol-based skincare products (face cream, body treatment, eye cream) and Tretinoin Face Cream Rx. One-time purchases with bundle discounts available.
4. Product Sales - Hair Care: Sales of oral minoxidil, spironolactone, and Lash & Brow Serum Rx for menopause-related hair loss. Billed quarterly.
5. Product Sales - Weight Care: Alloy Weight Care membership ($99/month) plus GLP-1 medication costs. Medications include branded options (Zepbound, Wegovy) and compounded alternatives starting at $70/month.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Alloy is a direct-to-consumer telehealth platform that provides personalized menopause and perimenopause care for women over 40, combining virtual consultations with Menopause Society Certified Practitioners (NCMP) and direct prescription fulfillment. Its core offerings include FDA-approved bioidentical hormone replacement therapy (estradiol pills, patches, sprays, gels, progesterone, paroxetine), the proprietary M4 estriol-based prescription skincare line, GLP-1 weight management medications (Zepbound, Wegovy, Foundayo, and compounded options), sexual health treatments, hair restoration products, and a gut health synbiotic, all dispensed through its online storefront at myalloy.com.

Product overview

Alloy is a telehealth platform offering comprehensive menopause and midlife care for women, structured as a multi-category health platform combining hormone replacement therapy, skincare, weight management, sexual health, hair care, and gut health products. The platform is built around menopause-specialized physicians providing personalized treatment plans delivered directly to patients. Core offerings include FDA-approved hormone therapies (Estradiol Pill, Patch, Spray, Gel, Progesterone), the proprietary M4 estriol-based skincare line, GLP-1 weight care medications (Zepbound, Wegovy, Foundayo, compounded options), sexual health treatments (Estradiol Vaginal Cream, O-mazing), and hair restoration products (Oral Minoxidil, Spironolactone, Lash & Brow Serum). All products require or include physician consultation with unlimited messaging access, positioning Alloy as a vertically-integrated menopause care ecosystem rather than a single-product solution.

Differentiator

Problem solved

Functional benefit

Brands

• M4 Skincare Collection: Prescription estriol-powered skincare line for menopause-related skin changes including M4 Face Cream Rx, M4 Body Treatment Rx, M4 Eye Cream Rx, and M4 Face Serum Rx.
• Alloy Weight Care

Products and services

• Estradiol Pill FDA-approved, plant-based, bioidentical oral estradiol tablet for alleviation of menopause symptoms including hot flashes, night sweats, low libido, anxiety, fatigue, and brain fog, prescribed through Alloy's menopause-specialist physicians.
• Estradiol Patch Transdermal estradiol patch providing bioidentical plant-based hormone replacement therapy for menopause symptoms, applied once or twice weekly for steady estrogen absorption through the skin.
• Evamist Estradiol Spray FDA-approved transdermal estradiol spray for menopause relief, applied to the inner forearm to deliver bioidentical plant-based estrogen through the skin.
• Estradiol Gel (Divigel) Transdermal estradiol gel applied daily to the thigh for menopause symptom relief, supplied as a bioidentical plant-based formula in individual packets for easy application.
• Progesterone Bioidentical progesterone supplement prescribed alongside estradiol to protect the uterine lining in women with an intact uterus.
• Paroxetine Non-hormonal FDA-approved selective serotonin reuptake inhibitor (SSRI) for relief from hot flashes and night sweats, prescribed to women who cannot take hormone therapy.
• Low-Dose Birth Control Pill Hormonal contraceptive option for women in perimenopause who are still experiencing menstrual periods.
• M4 Face Cream Rx Prescription estriol-based face cream clinically proven to improve skin elasticity, hydration, and overall skin health in menopausal women, with reported 88% improvement in elasticity and 68% improvement in skin health in 12 weeks.
• M4 Body Treatment Rx The only prescription estriol plus peptide body treatment clinically proven to smooth, firm, and restore skin on hands, arms, chest, and knees with visible results in 8 weeks.
• M4 Eye Cream Rx Prescription eye cream combining estriol with peptides to brighten, tighten, and reduce fine lines in the delicate eye area.
• M4 Face Serum Rx Estriol, peptides, and hyaluronic acid serum for smoothing, firming, and repairing skin with deep hydration and collagen-boosting properties.
• Tretinoin Face Cream Rx Prescription topical tretinoin cream compounded with niacinamide and aloe for treatment of acne, fine lines, hyperpigmentation, and discoloration.
• Zepbound (Tirzepatide) FDA-approved once-weekly tirzepatide injection for weight management, activating GIP and GLP-1 receptors to regulate appetite and support sustainable weight loss averaging 15-20% of body weight in 12 months.
• Wegovy (Semaglutide Pen) FDA-approved once-weekly semaglutide injection for weight management, mimicking natural GLP-1 hormone to regulate blood sugar, curb appetite, and support sustainable weight loss averaging 15% of body weight in 12 months.
• Wegovy Pill (Oral Semaglutide) FDA-approved daily oral GLP-1 medication for weight management providing an alternative to weekly injections, with average weight loss of 15% of body weight in 12 months.
• Foundayo Pill (Orforglipron) FDA-approved once-daily oral non-peptide small-molecule GLP-1 receptor agonist for weight management with no food or liquid restrictions, supporting average weight loss of 11.2% of body weight in 18 months.
• Compounded Semaglutide Customized GLP-1 injection prepared by a compounding pharmacy with personalized dosing options for gentler starts and individual goals; not available in AL, AR, CA, NV, LA, MS, and DC.
• Compounded Tirzepatide Customized dual-action GLP-1/GIP peptide injection activating both appetite (GLP-1) and metabolic efficiency (GIP) receptors with personalized dosing options.
• Compounded Liraglutide Daily GLP-1 injection with personalized dosing options for gentler starts and individual goals; not available in AL, AR, CA, NV, LA, MS, and DC.
• Estradiol Vaginal Cream FDA-approved plant-based bioidentical local hormone treatment for genitourinary symptoms of menopause including vaginal dryness, itching, burning, painful sex, and frequent UTIs, formulated as a non-systemic treatment safe to use with HRT.
• O-mazing Cream Prescription cream blend of sildenafil, pentoxifylline, ergoloid mesylates, and peppermint oil designed to enhance sexual arousal, increase blood flow, stimulate lubrication, and heighten physical sensations for more fulfilling orgasms.
• Oral Minoxidil Low-dose oral minoxidil daily pill for treatment of hair thinning and loss in menopausal women, stimulating and enlarging hair follicles for stronger, thicker hair growth within 3-6 months.
• Oral Spironolactone Anti-androgen daily pill for hormonal hair loss treatment in women, preventing further thinning by combating excess androgens, particularly effective for women with signs of elevated androgen levels.
• Lash & Brow Serum Rx (Generic Latisse) Prescription bimatoprost 0.03% topical solution for eyelash and eyebrow growth, clinically proven to support longer, darker lashes and thicker, fuller brows in as little as 8 weeks.
• Alloy Synbiotic Prebiotic and probiotic supplement (synbiotic) formulated specifically for perimenopausal and menopausal women, supporting healthy gut microbiome, immune system, hormonal balance, and weight control using Bacillus subtilis, Bacillus coagulans, and kiwifruit prebiotic fiber.

Quantifiable outcome

• 95% of Alloy customers taking HRT feel symptom relief in 2 weeks or less
• +5 more outcomes

Named customers5 records

Segments2 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Kansai Startup Academia Coalition (KSAC)coreStrategic or Co-development Partner · 22 July 2025Alloy Japan and KSAC (represented by Kyoto University) signed a Memorandum of Understanding on July 22, 2025, for a three-year collaboration to accelerate global expansion of university-affiliated life science startups across Japan. Alloy Japan will initially support KSAC's GAP Fund program, which provides funding to selected academic projects within KSAC's network of over 90 institutions in western Japan.
• MDI Health Technologies Ltd.coreTechnology or IntegrationMDI Health Technologies Ltd. is an independent medical group providing the network of United States-based healthcare providers who deliver telemedicine consultations through Alloy's platform. MDI Health providers are responsible for medical care, prescriptions, and Notice of Privacy Practices.
• LillyDirect (Eli Lilly)minorChannel Partner/ Reseller/ DistributorFor Zepbound and Foundayo Pill prescriptions, doctors send prescriptions to LillyDirect (Eli Lilly's pharmacy) which ships medications directly to patients.
• NovoCare (Novo Nordisk)minorChannel Partner/ Reseller/ DistributorFor Wegovy prescriptions, doctors send prescriptions to NovoCare (Novo Nordisk's pharmacy) which ships medications directly to patients.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Evernow: Evernow is a telehealth company offering hormone therapy and non-hormonal treatments for menopause symptoms delivered virtually. Closely comparable to Alloy's HRT-first menopause telehealth model and DTC cash-pay approach.
• Winona: Winona is a telehealth platform prescribing bioidentical hormone replacement therapy for perimenopause and menopause, with both oral and topical estrogen products. Directly overlaps Alloy on HRT product mix and menopause-focused virtual care model.
• Midi Health: Midi Health is a virtual care clinic specifically focused on menopause and perimenopause for women in midlife, offering hormone therapy, lifestyle, and specialist consultations. It is the most direct head-to-head competitor to Alloy in the NCMP-certified menopause telehealth category.
• Gennev: Gennev is a women's health platform offering menopause-focused telehealth, hormone therapy prescriptions, and dietitian support. Comparable to Alloy on the menopause telehealth category and integration of clinical care with wellness coaching.
• Elektra Health: Elektra Health provides a digital menopause care platform combining telehealth with evidence-based education and community for women in midlife. Directly comparable to Alloy on menopause telehealth services, target demographic, and women's midlife positioning.

Emerging players

• Tia: Tia operates a hybrid in-person and virtual women's health clinic network covering primary care, gynecology, and mental health. Comparable on women's health platform ambition, though it skews younger than Alloy's menopause-only demographic.
• Caraway Health: Caraway is a women's health startup providing virtual care for college-aged and younger women, including mental, physical, and reproductive health. Adjacent women's health platform with partial overlap on midlife-adjacent care delivery and brand-led DTC model.

Broad incumbents

• Maven Clinic: Maven Clinic is a virtual care platform for women's and family health spanning fertility, pregnancy, postpartum, and menopause. Comparable on women's health virtual care but broader across the life stages than Alloy's midlife focus.
• Ro: Ro is a large, well-capitalized direct-to-patient telehealth company that has expanded into women's health and midlife hormone care alongside its core men's health and weight care verticals. It is a broad incumbent with overlapping menopause offerings rather than a specialist.
• Hims & Hers Health: Hims & Hers is a publicly-traded telehealth and personal care brand that has expanded its women's health and weight care categories, with growing menopause-adjacent offerings. It is a broad incumbent with much larger marketing scale and category breadth than Alloy.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xtwitter.com/myalloy
• LinkedInlinkedin.com/company/alloy-health

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds3 records

Investors7 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alloy